Literature DB >> 26983001

New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae, Florida, USA(1).

Jun-Jie Li, L Silvia Munoz-Price, Caressa N Spychala, Dennise DePascale, Yohei Doi.   

Abstract

Entities:  

Keywords:  Enterobacteriaceae; Florida; Iran; Klebsiella pneumoniae; Middle East; NDM producers; NDM-1–producing; New Delhi metallo-β-lactamase-1–producing; USA; bacteria; homologous recombination; horizontal transfer; metallo-β-lactamase; reservoir

Mesh:

Substances:

Year:  2016        PMID: 26983001      PMCID: PMC4806972          DOI: 10.3201/eid2204.151176

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: New Delhi metallo-β-lactamase (NDM)–producing Enterobacteriaceae have swiftly spread worldwide since an initial report in 2008 from a patient who had been transferred from India back home to Sweden (). Epidemiologically, the global diffusion of NDM-1 producers has been associated with the Indian subcontinent and the Balkan region, which are considered the primary and secondary reservoirs of these pathogens, respectively (). However, recent reports suggest that countries in the Middle East may constitute another potential reservoir for NDM-1 producers (). More than 100 NDM-producing isolates have been reported in the United States, most of which were associated with recent travel from the Indian subcontinent (,). We report an NDM-1–producing Klebsiella pneumoniae strain that was recovered from a patient who had been transferred from Iran to a hospital in Florida, United States. The patient was a 72-year-old woman with diabetes who had suffered a hip fracture while residing in Iran. After fixation of the bone failed, the patient underwent hip replacement, which was complicated by dislocation and an infected hematoma. She was transferred to a hospital in Florida in February 2014 for further care. The wound culture collected upon arrival grew K. pneumoniae K351. The patient underwent surgical debridement, implant removal, and placement of an antimicrobial spacer for prosthetic joint infection. She was treated with tigecycline; however, the wound did not heal, and she underwent debridement with removal of the spacer and placement of antimicrobial beads. K. pneumoniae K351 from the patient was resistant to all β-lactams tested, including carbapenems, and highly resistant to aminoglycosides and fluoroquinolones, retaining susceptibility only to tigecycline and colistin. PCR and sequencing revealed the presence of β-lactamase genes blaNDM-1, blaCTX-M-15, blaSHV-12, and blaTEM-1 and 16S rRNA methyltransferase genes rmtC and armA. The strain sequence type (ST) was ST147, which is one of the predominant NDM-producing K. pneumoniae lineages and has been reported in many countries (,). Conjugation experiments using broth and filter mating methods did not yield any Escherichia coli J53 transconjugants with blaNDM-1, despite repeated attempts. Plasmids of K351 were extracted by using the standard alkaline lysis method and used to transform E. coli TOP10-competent cells. An E. coli transformant harboring plasmid pK351 grew on Mueller-Hinton agar plates supplemented with 200 μg/mL of ampicillin. The transformant exhibited resistance to all β-lactams, including carbapenems and aminoglycosides; this resistance could be attributed to the presence of blaNDM-1 and rmtC in plasmid pK351, which was confirmed by PCR. pK351 was fully sequenced on a PacBio RS II sequencing instrument (Pacific Biosciences, Menlo Park, CA) and annotated (GenBank accession no. KR351290) (). pK351 is 106,844 bp in length, has an average GC content of 55.4%, and encodes IncFIB and IncFII-like replication proteins, with IncFIB belonging to B36 according to the replicon sequencing typing scheme (). pK351 is most closely related (98% coverage and 99% identity) to 3 blaNDM-1-carrying plasmids pKOX_NDM1, pRJF866, and pNDM-Ec1GN574 (GenBank accession nos. NC_021501, KF732966, and KJ812998, respectively) (Technical Appendix Figure). Compared with the 3 plasmids, pK351 is missing a 4,086-bp region between insertion sequence (IS) IS1 and IS903-like mobile elements, probably due to IS1-mediated deletion. In addition, the region containing gene ccdBA between gene resD and an IS1 remnant is replaced by a region encoding 2 hypothetical proteins in pK351. The remainder of pK351 exhibits 99.95% identity to the 3 related plasmids. The immediate genetic environment of blaNDM-1 in pK351 is identical to that in the 3 related plasmids, encompassing blaNDM-1 itself and the downstream sequence, flanked by 256-bp direct repeats (). Plasmids pKOX_NDM1 and pRJF866 were found in a K. oxytoca strain from Taiwan and a K. pneumoniae ST11 strain from Shanghai, China, respectively (,). K. oxytoca (pKOX_NDM1) was isolated from a patient from Taiwan who underwent surgery in Jiangxi, China. K. pneumoniae ST11 (pRJF866) was isolated from a patient in a burn unit in Shanghai just after a highly related NDM-1–producing K. pneumoniae ST11 strain was isolated from another patient in the same unit who had traveled to Jiangxi Province (). pNDM-Ec1GN574 was detected in an E. coli strain from a patient previously hospitalized in India before being admitted to a community hospital in Canada (). Identification of highly similar blaNDM-1–carrying plasmids in various strain lineages and species in different locales suggests extensive horizontal transfer of these plasmids among broad-range hosts. Acquisition of these plasmids by globally distributed, multidrug-resistant K. pneumoniae lineages (ST11 and ST147) is of grave concern. The epidemiology of NDM-1–producing Enterobacteriaceae continues to evolve. The case reported here was imported to the United States upon patient transfer from Iran (). The unusual path for this NDM-1–producing K. pneumoniae supports the hypothesis that the Middle East might be an additional reservoir for NDM producers.

Technical Appendix

Major structural features of plasmid pK351 compared with closely related plasmids.
  10 in total

1.  Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants.

Authors:  Laura Villa; Aurora García-Fernández; Daniela Fortini; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2010-10-08       Impact factor: 5.790

2.  Complete sequences of two plasmids in a blaNDM-1-positive Klebsiella oxytoca isolate from Taiwan.

Authors:  Tzu-Wen Huang; Jann-Tay Wang; Tsai-Ling Lauderdale; Tsai-Lien Liao; Jui-Fen Lai; Mei-Chen Tan; Ann-Chi Lin; Ying-Tsong Chen; Shih-Feng Tsai; Shan-Chwen Chang
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

3.  Characterization of multiple NDM-1-producing Enterobacteriaceae isolates from the same patient.

Authors:  Nathalie Tijet; David Richardson; Gregory MacMullin; Samir N Patel; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

4.  Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota.

Authors:  Chang-Seop Lee; Shawn Vasoo; Fupin Hu; Robin Patel; Yohei Doi
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

5.  Complete sequence of a conjugative incn plasmid harboring blaKPC-2, blaSHV-12, and qnrS1 from an Escherichia coli sequence type 648 strain.

Authors:  Jun-Jie Li; Chang-Seop Lee; Ji-Fang Sheng; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

6.  NDM-1-producing Enterobacteriaceae in a teaching hospital in Shanghai, China: IncX3-type plasmids may contribute to the dissemination of blaNDM-1.

Authors:  Hongping Qu; Xiaoli Wang; Yuxing Ni; Jialin Liu; Ruoming Tan; Jie Huang; Lei Li; Jingyong Sun
Journal:  Int J Infect Dis       Date:  2015-03-02       Impact factor: 3.623

7.  Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1.

Authors:  Shereen Shoma; Muhammad Kamruzzaman; Andrew N Ginn; Jonathan R Iredell; Sally R Partridge
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-22       Impact factor: 2.803

8.  First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran.

Authors:  Fereshteh Shahcheraghi; Saman Nobari; Fatemeh Rahmati Ghezelgeh; Siavash Nasiri; Parviz Owlia; Vajihe Sadat Nikbin; Abbas Ali Imani Fooladi
Journal:  Microb Drug Resist       Date:  2012-09-17       Impact factor: 3.431

Review 9.  Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria.

Authors:  Laurent Dortet; Laurent Poirel; Patrice Nordmann
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

10.  Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae.

Authors:  Yohei Doi; Jessica A O'Hara; James F Lando; Ashley M Querry; Bethany M Townsend; Anthony W Pasculle; Carlene A Muto
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

  10 in total
  8 in total

1.  Diverse Vectors and Mechanisms Spread New Delhi Metallo-β-Lactamases among Carbapenem-Resistant Enterobacteriaceae in the Greater Boston Area.

Authors:  Nicole Pecora; Xiaomin Zhao; Kathleen Nudel; Maria Hoffmann; Ning Li; Andrew B Onderdonk; Deborah Yokoe; Eric Brown; Marc Allard; Lynn Bry
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.

Authors:  Martin Everett; Nicolas Sprynski; Alicia Coelho; Jérôme Castandet; Maëlle Bayet; Juliette Bougnon; Clarisse Lozano; David T Davies; Simon Leiris; Magdalena Zalacain; Ian Morrissey; Sophie Magnet; Kirsty Holden; Peter Warn; Filomena De Luca; Jean-Denis Docquier; Marc Lemonnier
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 3.  The rapid spread of carbapenem-resistant Enterobacteriaceae.

Authors:  Robert F Potter; Alaric W D'Souza; Gautam Dantas
Journal:  Drug Resist Updat       Date:  2016-09-19       Impact factor: 18.500

Review 4.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

5.  Mechanisms Involved in Acquisition of blaNDM Genes by IncA/C2 and IncFIIY Plasmids.

Authors:  Alexander M Wailan; Hanna E Sidjabat; Wan Keat Yam; Nabil-Fareed Alikhan; Nicola K Petty; Anna L Sartor; Deborah A Williamson; Brian M Forde; Mark A Schembri; Scott A Beatson; David L Paterson; Timothy R Walsh; Sally R Partridge
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.

Authors:  Alex J Holloway; JiehJuen Yu; Bernard P Arulanandam; Sarah M Hoskinson; Tonyia Eaves-Pyles
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

7.  KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniae.

Authors:  Jolene R Bowers; Darrin Lemmer; Jason W Sahl; Talima Pearson; Elizabeth M Driebe; Bette Wojack; Michael A Saubolle; David M Engelthaler; Paul Keim
Journal:  J Clin Microbiol       Date:  2016-08-10       Impact factor: 5.948

8.  New Delhi Metallo-beta-lactamase-producing Enterobacter Cloacae - A Rare Multidrug Resistance Strain in a Caucasian Woman.

Authors:  Suman Siddamreddy; Sreenath Meegada; Vasuki Dandu; Vijayadershan Muppidi; Ramya Bachu
Journal:  Cureus       Date:  2020-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.